Immunome Form 4 Filing Shows President And CEO Clay B Siegall Bought 100,000 Shares Of Stock At A Price Of $13.88/Share
Portfolio Pulse from Benzinga Newsdesk
Immunome's President and CEO, Clay B Siegall, has purchased 100,000 shares of the company's stock at $13.88 per share, as per a recent SEC Form 4 filing.
May 21, 2024 | 8:27 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Immunome's President and CEO, Clay B Siegall, has purchased 100,000 shares of the company's stock at $13.88 per share. This insider buying could signal confidence in the company's future prospects.
Insider buying is often seen as a positive signal by investors, indicating that those with the most knowledge of the company believe in its future success. This could lead to a short-term increase in the stock price as market participants react to the news.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100